Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Scott

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|September 28, 2010
Rheumatoid arthritisDavid L Scott, Frederick Wolfe, Tom W J Huizinga
Drug Safety|March 4, 2018
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?Ian C Scott, Samantha L Hider, David L Scott
Patient Preference and Adherence|July 23, 2013
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a reviewIsraa Al-Shakarchi, Nicola J Gullick, David L Scott
International Journal of Spine Surgery|May 11, 2016
Teardrop fracture following head-first impact in an ice hockey player: Case report and analysis of injury mechanismsJames J Yue, Paul C Ivancic, David L Scott
Clinical and Experimental Rheumatology|October 17, 2013
Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?Ian C Scott, Gabrielle H Kingsley, David L Scott
Journal of Psychosomatic Research|October 20, 2009
Illness beliefs predict disability in rheumatoid arthritisHelen Graves, David L Scott, Heidi Lempp, et al.
European Journal of Heart Failure|September 2, 2008
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trialsPaul A Scott, Gabrielle H Kingsley, David L Scott
Arthritis Research & Therapy|September 10, 2022
Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studiesFowzia Ibrahim, Margaret Ma, David L Scott, et al.
Rheumatology (Oxford, England)|November 18, 2009
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritisMargaret H Y Ma, Gabrielle H Kingsley, David L Scott
BMC Musculoskeletal Disorders|October 20, 2012
Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative studyHeidi Lempp, Darija Hofmann, Stephani L Hatch, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|September 28, 2010
Rheumatoid arthritisDavid L Scott, Frederick Wolfe, Tom W J Huizinga
Drug Safety|March 4, 2018
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?Ian C Scott, Samantha L Hider, David L Scott
Patient Preference and Adherence|July 23, 2013
Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a reviewIsraa Al-Shakarchi, Nicola J Gullick, David L Scott
International Journal of Spine Surgery|May 11, 2016
Teardrop fracture following head-first impact in an ice hockey player: Case report and analysis of injury mechanismsJames J Yue, Paul C Ivancic, David L Scott
Clinical and Experimental Rheumatology|October 17, 2013
Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?Ian C Scott, Gabrielle H Kingsley, David L Scott
Journal of Psychosomatic Research|October 20, 2009
Illness beliefs predict disability in rheumatoid arthritisHelen Graves, David L Scott, Heidi Lempp, et al.
European Journal of Heart Failure|September 2, 2008
Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trialsPaul A Scott, Gabrielle H Kingsley, David L Scott
Arthritis Research & Therapy|September 10, 2022
Defining the relationship between pain intensity and disease activity in patients with rheumatoid arthritis: a secondary analysis of six studiesFowzia Ibrahim, Margaret Ma, David L Scott, et al.
Rheumatology (Oxford, England)|November 18, 2009
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritisMargaret H Y Ma, Gabrielle H Kingsley, David L Scott
BMC Musculoskeletal Disorders|October 20, 2012
Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative studyHeidi Lempp, Darija Hofmann, Stephani L Hatch, et al.
Pageof 14